Mural Oncology PLC (MURA)
3.90
+0.14
(+3.72%)
USD |
NASDAQ |
May 02, 11:40
Mural Oncology Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 153.80M |
| Date | Value |
|---|---|
| September 30, 2022 | 136.07M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
136.07M
Minimum
Sep 2022
153.80M
Maximum
Sep 2023
144.93M
Average
144.93M
Median
Cash from Financing (Quarterly) Benchmarks
| Amarin Corp PLC | 0.083M |
| Jazz Pharmaceuticals PLC | -100.31M |
| Prothena Corp PLC | 0.483M |
| Iterum Therapeutics PLC | 0.589M |
| GH Research PLC | -0.041M |